RecruitingNCT06691321
Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Studying Pneumocystosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Principal Investigator
- Santiago Avila, PhDCenter for Research in Infectious Diseases (CIENI)
- Enrollment
- 60 target
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Center for Research in Infectious Diseases (CIENI), Mexico City, Tlalpan, Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06691321 on ClinicalTrials.govOther trials for Pneumocystosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT04851015Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii PneumoniaTodd C. Lee MD MPH FIDSA
- RECRUITINGPHASE4NCT06499233Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic DiseaseTongji Hospital
- ACTIVE NOT RECRUITINGNCT06431958Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis JiroveciiUniversity Hospital, Brest
- RECRUITINGPHASE2NCT05835479Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsMundipharma Research Limited
- RECRUITINGNCT07269314Introduction of Polymerase Chain Reaction (PCR) in Microbiology and ParasitologyFondazione IRCCS Policlinico San Matteo di Pavia
- ENROLLING BY INVITATIONNANCT03856229Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDSCentro de Investigación en. Enfermedades Infecciosas, Mexico